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Angiotropism in Cutaneous Melanoma: A Prognostic Factor
Strongly Predicting Risk for Metastasis
To the Editor:
The role of tumor vascularity in the neoplastic progression and
potentially the prognosis of cutaneous melanoma is of singular
importance (Barnhill et al, 1996). Both angiogenesis and vascular/
lymphatic invasion have been the focus of considerable study as
biologic phenomena and potential prognostic factors (Barnhill et al,
1996; Busam et al, 1996). Despite a number of studies on
microvessel density, as a correlate of angiogenesis, there are no
de®nitive data that such microvessel counts constitute a prognostic
factor in melanoma (Barnhill et al, 1996). Vascular and/or
lymphatic invasion, i.e., the presence of tumor aggregates within
the latter channels, has been thought to be a direct manifestation of
metastasis in progress and accordingly a prognostic factor (Busam et
al, 1996). In fact, the observation of vascular/lymphatic invasion in
tissue sections is exceedingly rare and often an artifact that can be
attributed to tortuous vascular channels folding back into the
vascular lumina and also tissue shrinkage resulting in the appearance
of a (false) vascular space. Thus at least in some instances the tumor
aggregates are in fact external to the vascular/lymphatic channel
rather than being intraluminal. As result we have questioned the
utility of microvessel quanti®cation and the practical value of
observing vascular invasion as prognostic factors in cutaneous
melanoma.
Because of the observations mentioned above and our previous
studies demonstrating a unique association between melanoma cells
and the abluminal surfaces of endothelial cells, we have focused on
this relationship between tumor (melanoma) cells and the external
surfaces of vessels both as a mechanism of tumor metastasis and as a
potential prognostic factor. Indeed we have identi®ed a hitherto
unrecognized image ± the angio-tumoral complex ± in which the
tumor cells and endothelium are in contact via an amorphous
matrix containing speci®c laminin(s), including potentially the b2
chain of laminin (Lugassy et al, 1997; 1999a, b). In the angio-
tumoral complex, endothelial cells show no sign of physiologic
damage, no tumoral intravasation, and tumor cells occupy a
pericytic location. Given the role of laminin in migration,
metastasis, and protease activity, we have suggested that this
periendothelial free-laminin is promoting the migration of mela-
noma cells over the mesenchymal surface of the endothelium. This
potential mechanism of tumor spread has been termed ``extra-
vascular migratory metastasis'', as opposed to intravascular tumor
spread (Lugassy et al, 1999b).
Angiotropism (melanoma cells cuf®ng the external surface of
vessels) is likely to be the histopathologic counterpart of the angio-
tumoral complex. We have noted angiotropism to be a much more
frequent pathologic ®nding than that of vascular or lymphatic
invasion. Thus angiotropism (and the angio-tumoral complex) may
not only potentially represent a mechanism of melanoma spread
along the external surface of endothelium via speci®c laminin(s),
but also a prognostic factor of metastasis.
We have studied the prognostic signi®cance of angiotropism as a
qualitative parameter, i.e., one that is recorded as present or absent
versus a continuous variable such as numbers of microvessels that
lends itself to quanti®cation, in a series of patients with primary
cutaneous melanoma and documented metastasis matched with a
similar group of patients with nonmetastasizing primary mela-
nomas. The cases were retrieved from the following institutions:
the Massachusetts General Hospital, Brigham and Women's
Hospital, Johns Hopkins Hospital, George Washington
University Medical Center, and the institutions cooperating with
the Cancer Prevention Research Unit at Yale University. Eighty
patients with one or two representative slides and de®nite outcomes
or follow-up were enrolled in the study. The 80 patients comprised
two groups: (i) 40 patients with melanomas metastasizing to
regional lymph nodes, visceral sites, or both, and (ii) 40 patients
with nonmetastasizing melanomas and long-term disease-free
follow-up (range 5±22 y, mean 10.77 y). Another component of
the study involved the matching of patients from the two groups
above for the following major prognostic factors: tumor thickness
in millimeters (usually allowing no more than a 20% difference);
age in years (usually no more than a decade difference); gender, i.e.,
males were matched with males and females with females; and
anatomic site matched for three major regions ± head and neck,
trunk, and extremities. Twenty-six pairs of patients resulted from
this matching. In general only one or two slide(s) from each
melanoma were available for review, and this slide or slides was
comprehensively assessed by a single observer (RLB) for angio-
tropism and vascular/lymphatic invasion without knowledge of
patient outcome. All tissue sections on each microslide or slides
were systematically studied microscopically for evidence of
angiotropism (as de®ned below) at the advancing front of the
melanoma and up to 1±2 mm beyond the main tumor mass.
Among the two groups of patients with and without metastases,
each comprised of 40 melanomas, 99 and 71 tissue sections,
respectively, were reviewed from each group. For the vast majority
of cases in both groups only one or two tissue sections were
available for review. Among the cases with de®nite angiotropism
®ve or six tissue sections were available for each of ®ve cases,
whereas among 12 cases without angiotropism four to eight tissue
sections per case were available for study. Thus number of sections
available for review did not in¯uence signi®cantly the likelihood of
detecting angiotropism. Serial step sections were not performed as
the tissue block was not available for almost all of the tumors.
Angiotropism was de®ned as multiple melanoma cells singly
disposed along or in aggregates closely opposed to the external
surfaces of (and not within) microvessels and/or lymphatics at the
advancing front and/or some distance (1±2 mm) away from the
main part of the tumor (Fig 1). Angiotropism was graded as (i)
absent (absence of tumor cells clearly cuf®ng vessels), (ii) equivocal
(a single focus of tumor cells clearly cuf®ng a vessel), or (iii)
de®nitely present (two or more foci of tumor cells clearly cuf®ng a
vessel). Angiotropic melanoma cells were recognized by their
unequivocal similarity to nearby melanoma cells; if there was any
question about the identity of the cells cuf®ng vessels the case was
scored as negative for angiotropism. Five cases with de®nite
angiotropism underwent immunostaining with polyclonal anti-
bodies directed against S 100 protein and CD 31, a vascular marker,
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to determine if such immunostaining of angiotropic melanoma
would aid in the recognition of angiotropism.
Among the 40 pairs of patients, there were no signi®cant
differences with respect to age (mean 50.7 y for patients with
metastases versus 53.0 y for patients without metastases, p = 0.543,
Student's two-tailed t test); however, patients with metastasizing
melanomas had thicker melanomas than those without metastases
(2.2 mm vs 1.6 mm, p = 0.016). The 40 patients with metastasizing
melanomas showed de®nite angiotropism (Fig 1a) in 16 cases and
equivocal angiotropism in ®ve cases versus no de®nite angiotropism
in any case and equivocal angiotropism in six cases among the 40
melanomas without metastasis (p = 0.00005, Fisher's exact test).
Melanomas with angiotropism had a mean thickness of 2.3 mm and
thus were signi®cantly thicker than melanomas without metastases
(p = 0.0058). We found vascular/lymphatic invasion in only a
single patient who had metastatic melanoma and also exhibited
angiotropism. When the 26 matched pairs of patients were
examined, there were no differences in age and tumor thickness
(Table I). Seven patients with metastatic melanoma demonstrated
de®nite and three equivocal angiotropism, however, versus no
de®nite angiotropism and only two melanomas with equivocal
angiotropism in the group without metastases (p = 0.008).
Although there were too few cases for a de®nitive analysis, the
presence or absence of angiotropism did not appear to have any
effect on survival among the patients with metastases. Any potential
effect of angiotropism on survival, however, requires further study
with a larger number of patients and longer follow-up.
Immunostaining of the ®ve cases with S 100 protein enhanced
the recognition of angiotropic melanoma cells (Fig 1b). The
immunostaining with S 100 protein was not more sensitive than
conventional microscopy but instead simply validated the obser-
vation of angiotropism. There was no signi®cant bene®t from the
use of CD 31.
These ®ndings demonstrate that angiotropism as de®ned here is
more commonly observed histopathologically than vascular/
lymphatic invasion in melanoma. A major outcome from this
study was to show that angiotropism can be easily recognized by
light microscopy in routine tissue sections of melanoma. The use of
S 100 protein may facilitate the recognition or con®rmation
of angiotropism, particularly for those not experienced with this
phenomenon. Furthermore our results strongly suggest that
angiotropism is an important prognostic factor correlating with
metastasis. Based on these qualitative results, we are in the process
of carrying out more quantitative studies supplemented by
immunohistochemistry with S 100 protein to con®rm these
observations.
Raymond Barnhill, Katrina Dy, Claire Lugassy, Departments of
Dermatology and Pathology, George Washington University,
Washington, D.C. 20037, U.S.A.
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Table I. Analysis of 26 patients with primary melanoma
associated with metastases matched with 26 patients
without metastases
Characteristic Metastases Non-metastases p-value
Age 55.8 ya 52.1 y 0.383b
Tumor thickness 2.1 mma 1.9 mm 0.341
Angiotropism
Absent 13 24
Equivocal 3 2
Present 7 0 0.008c
aMean.
bStudent's two-tailed t test.
cFisher's exact test.
Figure 1. (a) Primary malignant melanoma, invasive, with measured
depth of 3.2 mm and demonstrating angiotropism, and melanoma cells
identi®ed by immunostaining with S 100 protein cuf®ng two
microvessels (arrows). (b) Cutaneous melanoma with angiotropism.
(Scale bar = 50mm).
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